D. E. Shaw & Co., Inc. CHINA BIOLOGIC PRODS HLDGS I Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Shares

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	N/A	-21,714 Closed	0 $0
Q1 2021 May 17, 2021	SELL	N/A	-8,703 Reduced 28.61%	21,714 $2.57 Million
Q4 2020 Feb 16, 2021	SELL	N/A	-6,690 Reduced 18.03%	30,417 $3.59 Million
Q3 2020 Nov 16, 2020	BUY	N/A	8,506 Added 29.74%	37,107 $4.12 Million
Q2 2020 Aug 14, 2020	SELL	N/A	-5,857 Reduced 17.0%	28,601 $2.92 Million
Q1 2020 May 15, 2020	SELL	N/A	-17,327 Reduced 33.46%	34,458 $3.72 Million
Q4 2019 Feb 14, 2020	SELL	N/A	-2,500 Reduced 4.61%	51,785 $6.03 Million
Q3 2019 Nov 14, 2019	BUY	N/A	10,813 Added 24.87%	54,285 $6.21 Million
Q2 2019 Aug 14, 2019	SELL	N/A	-65,615 Reduced 60.15%	43,472 $4.14 Million
Q1 2019 May 15, 2019	SELL	N/A	-18,573 Reduced 14.55%	109,087 $9.95 Million
Q4 2018 Feb 14, 2019	BUY	N/A	27,213 Added 27.09%	127,660 $9.69 Million
Q3 2018 Nov 14, 2018	SELL	N/A	-79,026 Reduced 44.03%	100,447 $8.04 Million
Q2 2018 Aug 14, 2018	BUY	N/A	74,459 Added 70.9%	179,473 $17.8 Million
Q1 2018 May 15, 2018	SELL	N/A	-78,255 Reduced 42.7%	105,014 $8.51 Million
Q4 2017 Feb 14, 2018	BUY	N/A	85,135 Added 86.75%	183,269 $14.4 Million
Q3 2017 Nov 14, 2017	BUY	N/A	98,134	98,134 $9.06 Million

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.